RNXT · RenovoRx, Inc. · Executive Compensation
Market Cap
$74.91M
Shares
45.13M
Volume · Oct 2
269.37K
Avg daily vol (3M)
745.21K
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
Fiscal 2025
| Executive | Role | Total |
|---|---|---|
| Shaun Bagai | CEO | $1,232,317 |
| Shaun R. Bagai | Chief Executive Officer | $1,232,317 |
| Ramtin Agah | Chief Medical Officer | $692,246 |
| Ronald Kocak | — | $616,696 |
| Ronald B. Kocak | Vice President, Controller and Principal Accounting Officer | $616,696 |
Fiscal 2024
| Executive | Role | Total |
|---|---|---|
| Shaun Bagai | CEO | $1,226,050 |
| Shaun R. Bagai | Chief Executive Officer | $1,226,050 |
| Leesa Gentry | Chief Clinical Officer | $890,151 |
| Ramtin Agah | Chief Medical Officer | $603,019 |
Fiscal 2023
| Executive | Role | Total |
|---|---|---|
| Shaun Bagai | CEO | $936,779 |
| Shaun R. Bagai | Chief Executive Officer | $936,779 |
| Angela Gill Nelms | Former Chief Operating Officer | $547,634 |
| Ramtin Agah | Chief Medical Officer | $506,772 |
| Leesa Gentry | Chief Clinical Officer | — |
Fiscal 2022
| Executive | Role | Total |
|---|---|---|
| Shaun Bagai | CEO | $841,074 |
| Shaun R. Bagai | Chief Executive Officer | $841,074 |
| Angela Gill Nelms | Former Chief Operating Officer | $707,288 |
| Ramtin Agah | Chief Medical Officer | $434,655 |
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Ramtin Agah, M.D. | Executive Chairman | Appointed | 2026-03-27 |
| Mark Voll | Chief Financial Officer | Appointed | 2026-02-06 |
| Ronald B. Kocak | Principal Accounting Officer | Resigned | 2026-02-06 |
| Leesa Gentry | Chief Clinical Officer | Appointed | 2024-03-14 |
| Leesa Gentry | Chief Clinical Officer | Appointed | 2024-02-23 |
| Angela Gill Nelms | Chief Operating Officer | Resigned | 2024-02-23 |
| Ronald B. Kocak | Vice President, Controller and Principal Accounting Officer | Appointed | 2024-02-09 |
| James Ahlers | Chief Financial Officer | Resigned | 2024-02-09 |
| Robert Spiegel, M.D., FACP | independent director | Appointed | 2023-04-27 |
| Angela Gill Nelms | Chief Operating Officer | Appointed | 2022-09-19 |
| James Ahlers | Secretary | Appointed | 2022-07-19 |
| James Ahlers | Chief Financial Officer | Appointed | 2022-07-19 |
| Christopher J. Lehman | Chief Financial Officer | Resigned | 2022-07-19 |